regarding the michigan pancreatic trial
it has already been discussed that the triple trial protocol has a different schedule for the introduction of vis than the schedule for gem/vis in the michigan trial. so, to say that if the mich trial works then the triple trial should be even better would require scientific knowledge for this specific issue - at a level greater than anyone on these boards possesses, in my opinion. it is wishful thinking for all of us, but not based on scientific expertise. it is much like saying that this should have been an $8 stock many months ago.
Sentiment: Hold